UFDA bans drugs import from Badrivishal Chemicals
The Dollar Business Bureau The US Food and Drug Administration (USFDA) has restricted imports of drugs from Pune-based Badrivishal Chemicals & Pharmaceuticals. The US drug regulator has issued the alert under Import Alert 66-40, which authorises the health regulator "detention without physical examination of drugs from firms which have not met drug GMPs". The company manufactures active pharmaceutical ingredients and specialty chemicals and exports its drugs to more than 30 countries including US, UK, Germany and France. Badrivishal Chemicals & Pharmaceuticals’s Pune-based plant is approved by Maharashtra FDA and is spread across an area of over 12,000 square feet. Another Indian drug major, Zydus Discovery, a research subsidiary of Cadila Healthcare, has also been pulled up by the USFDA for misbranding Saroglitazar, a drug used to treat ...
India to promote manufacturing of medicinal plants
The Dollar Business Bureau Despite sincere efforts by the National Medicinal Plants Board (NMPB) under Ministry of Ayurvedic, Unani, Siddha and Homoeopathy (AYUSH), Government of India, to ensure overall development of medicinal plants, the industry still perceives difficulties in procurement of the same. According to the Ministry of AYUSH, certain medicinal plants are threatened and endangered, thereby resulting in shortage of supply. Because of this reason, the industry finds it difficult in the procurement of medicinal plant materials like Guggul (Commiphora wightii), Katuki (Picrorrhiza Kurroa), Kuth (Saussurea lappa), Jatamansi (Nardostachys Jatamansi), among many others, informed the Shripad Yesso Naik, Minister of State, AYUSH, on Friday. Under NMPB, the government’s developmental activities under promotion of medicinal plants include conservation, cultivation, processing ...
